Sedlák J - Search Results

1

Preparation, properties and anticancer effects of mixed As₄S₄/ZnS nanoparticles capped by Poloxamer 407.

Bujňáková Z, Baláž M, Zdurienčíková M, Sedlák J, Čaplovičová M, Čaplovič Ľ, Dutková E, Zorkovská A, Turianicová E, Baláž P, Shpotyuk O, Andrejko S. Bujňáková Z, et al. Among authors: sedlak j. Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:541-551. doi: 10.1016/j.msec.2016.10.041. Epub 2016 Oct 19. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 27987742

2

Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview).

Baláž P, Sedlák J. Baláž P, et al. Among authors: sedlak j. Toxins (Basel). 2010 Jun;2(6):1568-81. doi: 10.3390/toxins2061568. Epub 2010 Jun 21. Toxins (Basel). 2010. PMID: 22069650 Free PMC article. Review.

3

Realgar (As4S4) nanoparticles and arsenic trioxide (As2O3) induced autophagy and apoptosis in human melanoma cells in vitro.

Pastorek M, Gronesova P, Cholujova D, Hunakova L, Bujnakova Z, Balaz P, Duraj J, Lee TC, Sedlak J. Pastorek M, et al. Among authors: sedlak j. Neoplasma. 2014;61(6):700-9. doi: 10.4149/neo_2014_085. Neoplasma. 2014. PMID: 25150315

4

A Structural Analysis of the Angucycline-Like Antibiotic Auricin from Streptomyces lavendulae Subsp. Lavendulae CCM 3239 Revealed Its High Similarity to Griseusins.

Matulova M, Feckova L, Novakova R, Mingyar E, Csolleiova D, Zduriencikova M, Sedlak J, Patoprsty V, Sasinkova V, Uhliarikova I, Sevcikova B, Rezuchova B, Homerova D, Kormanec J. Matulova M, et al. Among authors: sedlak j. Antibiotics (Basel). 2019 Jul 25;8(3):102. doi: 10.3390/antibiotics8030102. Antibiotics (Basel). 2019. PMID: 31349574 Free PMC article.

5

Potential biomarkers of exosomal cargo in endocrine signaling.

Zduriencikova M, Gronesova P, Cholujova D, Sedlak J. Zduriencikova M, et al. Among authors: sedlak j. Endocr Regul. 2015 Jul;49(3):141-50. doi: 10.4149/endo_2015_03_141. Endocr Regul. 2015. PMID: 26238497 Review.

6

Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells.

Barancik M, Bohacova V, Gibalova L, Sedlak J, Sulova Z, Breier A. Barancik M, et al. Among authors: sedlak j. Int J Mol Sci. 2012;13(1):369-82. doi: 10.3390/ijms13010369. Epub 2011 Dec 28. Int J Mol Sci. 2012. PMID: 22312258 Free PMC article.

7

Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.

Sedlák J, McGown A, Hrubisko M, Hunáková L, Chorváth B. Sedlák J, et al. Neoplasma. 1994;41(5):259-62. Neoplasma. 1994. PMID: 7854495

8

Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane.

Hunakova L, Gronesova P, Horvathova E, Chalupa I, Cholujova D, Duraj J, Sedlak J. Hunakova L, et al. Among authors: sedlak j. Toxicol Lett. 2014 Nov 4;230(3):479-86. doi: 10.1016/j.toxlet.2014.08.018. Epub 2014 Aug 23. Toxicol Lett. 2014. PMID: 25159039

9

Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells.

Duraj J, Hunakova L, Bodo J, Jakubikova J, Chovancova J, Sedlak J. Duraj J, et al. Among authors: sedlak j. Neoplasma. 2009;56(3):208-14. doi: 10.4149/neo_2009_03_208. Neoplasma. 2009. PMID: 19309223

10

Effective gene transfer to melanoma cells using bacterial ghosts.

Kudela P, Paukner S, Mayr UB, Cholujova D, Kohl G, Schwarczova Z, Bizik J, Sedlak J, Lubitz W. Kudela P, et al. Among authors: sedlak j. Cancer Lett. 2008 Apr 8;262(1):54-63. doi: 10.1016/j.canlet.2007.11.031. Epub 2007 Dec 31. Cancer Lett. 2008. PMID: 18164809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page